Home > Insider Trading > Filing (0000899243-21-003535)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1571498	Epizyme Inc.	EPZM	Pharmaceutical Preparations (2834)	261349956

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1620152	B Robert Bazemore	C/O Epizyme, Inc. 400 Technology Square Cambridge MA 02139	President & Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.0001	Disposition	2021-01-25	6,069	$11.41	248,367	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

Represents shares automatically sold by the reporting person to satisfy tax withholding obligations in connection with the vesting of the restricted stock units granted under the issuer's 2013 Stock Incentive Plan on January 24, 2019. The automatic sale of the reporting person's shares is provided for in a restricted stock unit agreement constituting a "binding contract" consistent with the affirmative defense to liability under Rule 10b5-1 and the sale does not represent a discretionary trade by the reporting person.
The reporting person acquired (i) 708 shares of Common Stock under the Issuer's 2013 Employee Stock Purchase Plan (the "2013 ESPP") on August 31, 2018, (ii) 1,120 shares of Common Stock under the 2013 ESPP on February 28, 2019, (iii) 971 shares of Common Stock under the 2013 ESPP on August 31, 2019, and (iv) 996 shares of Common Stock under the 2013 ESPP on February 29, 2020 that were not previously reported on Form 4.
The reporting person acquired 543 shares of Common Stock under the 2013 ESPP on August 31, 2020.